A carregar...
Navigating the Fas lane to improved cellular therapy for cancer
Genetically engineered T cells have shown promising activity in the treatment of cancer. However, these cells are also potentially susceptible to immune-suppressive pathways in the tumor microenvironment that may limit their efficacy. In this issue of the JCI, Yamamoto et al. describe a new cellular...
Na minha lista:
| Publicado no: | J Clin Invest |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society for Clinical Investigation
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6436865/ https://ncbi.nlm.nih.gov/pubmed/30830880 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI127581 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|